Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

KRAS Withdrawal in Cholangiocarcinoma Leads to Immune Infiltration and Tumor Regression

Advanced Science(2025)10.1002/advs.202511312Source: DataRank Database

KRAS Withdrawal in Cholangiocarcinoma Leads to Immune Infiltration and Tumor Regression is a research paper published in Advanced Science (2025). On theSindex it has a DataRank of 0. It has been cited 1 time.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access1 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (9 grants)Impact (FWCI 1.12)OA: goldTopics (31)IDs (PubMed, PMC, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Matthew Yee ORCID,Chaitanya N. Parikh ORCID,Boyang Ma ORCID,Yueying Cao,Yu‐Huan Shih

Live enrichment

PubMed:41332325 PMC:PMC12866855 OpenAlex:https://openalex.org/W4416940956

National Institutes of Health

Grant: R01CA275945

National Institutes of Health

Grant: R01GM150279

National Institutes of Health

Grant: P01HL158506

National Institutes of Health

Grant: UH3HL147367

National Cancer Institute

Grant: R00CA241110

National Cancer Institute

Grant: R37CA282805

Friedreich's Ataxia Research Alliance

FWCI

1.12

Citation Percentile

0.8%

Citation Trend

2026

goldLicense: cc-by

journalhttps://doi.org/10.1002/advs.202511312

publisherhttps://doi.org/10.1002/advs.202511312

publisherhttps://advanced.onlinelibrary.wiley.com/doi/pdf/10.1002/advs.202511312

publisherhttps://advanced.onlinelibrary.wiley.com/doi/full-xml/10.1002/advs.202511312

repositoryhttps://pubmed.ncbi.nlm.nih.gov/41332325

Fields of Study

Cholangiocarcinoma and Gallbladder Cancer StudiesLiver Diseases and ImmunityChemokine receptors and signalingAnimalsCholangiocarcinomaMiceProto-Oncogene Proteins p21(ras)Bile Duct NeoplasmsDisease Models, AnimalMice, KnockoutHumans

MeSH Terms

AnimalsBile Duct NeoplasmsDisease Models, AnimalHumansProto-Oncogene Proteins p21(ras)CholangiocarcinomaMice, KnockoutMice

Keywords

KRASBlockadeCytokineTumor progressionTumor microenvironmentOncogeneInfiltration (HVAC)Immune systemCholangiocarcinomaOncologyBiliary MalignancyKras Inhibition